Depression and Adherence in Head and Neck Cancer
2 other identifiers
observational
185
1 country
1
Brief Summary
Primary Objectives:
- Develop and pilot test an innovative intervention to determine its feasibility and acceptability to patients. Recruitment rate, patient satisfaction, attendance, questionnaire completion rates and the reliability and validity of the questionnaires will be assessed.
- Conduct preliminary analyses on the efficacy of the intervention in improving patients' depression. Evaluate whether depression levels in patients receiving the intervention decreases, and whether the decrease is greater among those who complete more sessions.
- Test the relationship between patients' depression levels and adherence to swallowing rehabilitation and to dental preventive maintenance regimens.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2005
CompletedFirst Submitted
Initial submission to the registry
July 6, 2007
CompletedFirst Posted
Study publicly available on registry
July 10, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 9, 2026
March 1, 2026
21.8 years
July 6, 2007
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recruitment rate, Patient satisfaction, Attendance, Questionnaire Completion Rates (questionnaire responses)
5 Years
Study Arms (1)
Questionnaire + Depression Intervention
Interventions
Questionnaire regarding mood, coping with cancer, how closely you follow your treatment schedule, your thoughts, your demographic information (such as age and race), and your medical history. If the answers to your questionnaire indicate that you may be depressed, you will be offered the intervention portion of the study.
Sessions given over 7 weeks and each lasting 30-45 minutes, that use "cognitive-behavioral" techniques.
Eligibility Criteria
Study participants with stage I-IV Head and Neck Cancer.
You may qualify if:
- Stage I-IV
- At least 18 years of age
- Speak and read English at a 7th grade level
- Are oriented to time, person, and place
- Have a Zubrod performance status of 0-3.
- To be eligible for the pilot depression intervention patients must score 9 or above on the Patient Health Questionnaire (PHQ-9). Additionally, if a patient has an elevated PHQ score and does not meet the cutoff but expresses a desire to be in the intervention in order to relieve his or her depression, then the PI will contact the participant to further assess eligibility for the intervention. Patients who do not make the cut-off will still be included in the study's statistical analyses.
You may not qualify if:
- \. Do not have other cancer diagnoses, excepting non-melanoma skin cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eileen H. Shinn, PhD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2007
First Posted
July 10, 2007
Study Start
March 15, 2005
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03